Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks to rise ahead of non-farm payrolls report

(Sharecast News) - London stocks were set to rise at the open on Friday as investors eyed the latest US non-farm payrolls report, and continued to mull 75-basis point rate hikes by the Federal Reserve and the Bank of England this week.

The FTSE 100 was called to open 40 points higher at 7,228.

CMC Markets analyst Michael Hewson said: "It was another tough day for European and US markets yesterday in the wake of concerns that the Federal Reserve's aggressive stance on inflation will drive the global economy into recession, as the soaring US dollar exports an inflationary shock across the world.

"Asia markets have managed to stabilise somewhat with Chinese markets surging on more unsubstantiated reports that the Chinese government is looking at a reopening strategy.

"While the FTSE100 saw a positive session yesterday that was more to do with the weakness of the pound with the Bank of England once again delivering a muddled message when it comes to monetary policy."

As far as the payrolls report is concerned, Hewson said expectations are for jobs growth to 195,000, which would be the lowest number this year, while the unemployment rate is set to tick back up to 3.6%.

In corporate news, Morgan Advanced Materials lifted profit and revenue guidance as sales for the first nine months of the year rose 10.5%.

The company said it now expected full year organic constant-currency growth to be in the range 7-9%, above previous guidance, and adjusted operating profit to be marginally above the top end of current analysts' forecasts.

Drugmaker AstraZeneca said that its Beyfortus asset had received European Union approval for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants.

AstraZeneca stated that Beyfortus was now the first and only single-dose RSV passive immunisation for the broad infant population, including those born healthy, at term or pre-term, or with specific health conditions.

Share this article

Related Sharecast Articles

London midday: FTSE stays up ahead of US inflation
(Sharecast News) - London stocks were off earlier highs but still in the black by midday on Wednesday, helped along by the likes of Experian and Imperial Brands, as investors eyed the latest US inflation reading.
London open: Stocks gain ahead of US inflation; Experian surges
(Sharecast News) - London stocks rose in early trade on Wednesday, helped along by the likes of Experian and Imperial Brands, as investors eyed the latest US inflation reading.
London pre-open: Stocks seen up ahead of US CPI
(Sharecast News) - London stocks were set to rise at the open on Wednesday following a positive session on Wall street, as investors eyed the latest US inflation reading.
London close: Stocks manage gains as unemployment rises
(Sharecast News) - London stocks closed higher on Tuesday, as investors analysed the latest UK jobs data and remarks from Bank of England chief economist Huw Pill.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.